Skip to main content
. 2016 Jul 22;21(7):956. doi: 10.3390/molecules21070956

Figure 5.

Figure 5

Effect of QXJYD treatment on the expression of Bax and Bcl-2 in VSMCs. (A) Immunohistochemistry analysis was performed to determine the protein expression of Bax and Bcl-2 in thoracic aorta from each group (n = 8). Images were representatives taken at a magnification of 20×; (B) Quantification of the mean expressions of Bax and Bcl-2 protein; (C) The mRNA expressions of Bax and Bcl-2 was examined by real-time PCR. All values were represented as mean ± SD; * p < 0.01 compared to WKY group, Δ p < 0.05 compared to SHR-control group.